WHITNEY WHITAKER: Open Payments
NPI 1013559848 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,090 in 150 payments from 19 companies in 2025. Trend: 2023 $93 · 2024 $529 · 2025 $3,090
Food & beverage: $2,990Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $457 |
| Novartis Pharmaceuticals Corporation | 15 | $381 |
| UCB, Inc. | 19 | $372 |
| Janssen Biotech, Inc. | 11 | $302 |
| Amgen Inc. | 19 | $236 |
| GlaxoSmithKline, LLC. | 9 | $228 |
| E.R. Squibb & Sons, L.L.C. | 11 | $212 |
| PFIZER INC. | 11 | $210 |
| AstraZeneca Pharmaceuticals LP | 8 | $162 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $103 |
Products named: Bimzelx, RINVOQ, TREMFYA, BENLYSTA, ORENCIA, XELJANZ, SKYRIZI, COSENTYX.
Industry payments across KY — which companies pay providers there.
